Encapsulated Papillary Carcinoma Membrane Characteristics
This study focused on encapsulated papillary carcinoma (EPC), a type of breast carcinoma characterized by a thick fibrous capsule-like structure surrounding the tumor, often interpreted as a thickened basement membrane (BM). The primary objective was to investigate the geometric properties of the EPC capsule and determine whether it results from an expansion of the native BM or arises from stromal reactive processes.
To accomplish this, the study examined 100 cases categorized into four groups: EPC, ductal carcinoma in situ (DCIS), normal breast tissue, and invasive tumors. An additional control group included encapsulated papillary thyroid carcinoma (EPTC). The researchers utilized picrosirius red (PSR) staining and polarized microscopy to analyze representative tissue slides. Image analysis software, including ImageJ, CT-FIRE, and Curve align, aided in extracting quantitative data.
The findings indicated several distinctive characteristics of the EPC capsule compared to other groups. In the EPC group, collagen fiber width, straightness, and density were notably increased, while fiber length decreased significantly. The arrangement of collagen fibers within the EPC capsule displayed less alignment and a more perpendicular orientation. Furthermore, this capsule was enriched with disorganized collagen type I fibers (stromal collagen). In terms of thickness, distribution, and fiber organization, the EPC capsule exhibited substantial intracapsular heterogeneity.
Compared to BM-like material in the invasive tumor group, the EPC capsule had a higher density of collagen fibers that were longer, straighter, and better aligned. However, there were no differences in the distribution of collagen types I and III. Interestingly, when compared to EPTC, the EPC and EPTC capsules were largely similar, except that the fibers within the EPC capsule appeared straighter. Notably, both normal ducts and lobules and DCIS BM displayed differences in collagen fiber density, straightness, orientation, and alignment when compared to the EPC capsule.
The study’s findings suggest that the EPC capsule is a reactive process rather than a manifestation of a thickened native BM, as seen in normal and in situ lesions. These observations provide further evidence supporting the notion that EPC is an indolent invasive carcinoma, as implied by the characteristics of its capsule.
This study focused on papillary lesions of the breast, particularly encapsulated papillary carcinoma (EPC). These lesions exhibit fibrovascular cores covered by epithelial cells, ranging from benign to malignant. EPC presents as well-circumscribed masses with a capsule-like structure, initially thought to be a thickened basement membrane (BM). This BM typically separates epithelial and myoepithelial cells from surrounding tissue. The study aimed to determine if the EPC capsule represents a reactive process similar to invasive tumors or an expansion of the native BM, resembling some cases of ductal carcinoma in situ (DCIS). The investigation utilized collagen staining techniques to analyze the capsule’s geometric characteristics.
- Cases of breast tissue, including normal and neoplastic samples.
- Patients who presented to Nottingham City Hospital, Nottingham, UK between 1999 and 2006.
- Four groups of cases, including encapsulated papillary carcinoma (EPC), ductal carcinoma in situ (DCIS), normal breast tissue, and invasive carcinoma (INV).
- Additional encapsulated papillary thyroid carcinoma (EPTC) cases for comparison.
- Freshly cut, 4-μm thick, full-face tissue sections for analysis.
- Tissue sections stained with picrosirius red (PSR) stain for collagen assessment.
- Cases not meeting the specified inclusion criteria.
- Tissue sections that were not properly stained with picrosirius red (PSR) for collagen analysis.
- Cases from outside the defined time frame (1999-2006) or location (Nottingham City Hospital, Nottingham, UK).
- Cases not falling into one of the four specified groups (EPC, DCIS, normal breast tissue, INV).
- Inadequate or damaged tissue sections that cannot be accurately analyzed.
- Cases with incomplete or missing clinical information.
Statistical analyses were conducted with a significance threshold set at P<0.05. The analyses were performed using either SPSS version 26 (IBM, Armonk, NY, USA) or GraphPad Prism (Boston, MA, USA). Various statistical tests, including Kruskal–Wallis, one-way analysis of variance (ANOVA), chi-square test, paired T-test, and Wilcoxon signed ranks tests, were applied as appropriate based on the specific context of each analysis. Graphs and tables were generated using GraphPad Prism software. The results are presented as the mean ± standard deviation (SD) unless otherwise specified.
The study found that encapsulated papillary carcinoma (EPC) exhibited a significantly thicker capsule (59.65 ± 18.50 µm) compared to basement membranes (BMs) in normal breast tissue (0.032 ± 0.009 µm) and ductal carcinomas in situ (DCIS) (0.058 ± 0.017 µm). However, there was no significant difference between the BM thickness of DCIS and normal breast tissue. EPC capsules also showed a significantly higher collagen density (53.47 ± 4.27 pixels) compared to both normal breast tissue (18.43 ± 5.06 pixels) and DCIS (25.94 ± 8.02 pixels). The majority of collagen in EPC capsules was collagen type I, whereas normal breast tissue and DCIS BMs contained less collagen type I. EPC capsules had wider, shorter, and straighter collagen fibers compared to normal and DCIS BMs. Moreover, EPC capsules displayed less fiber alignment than normal and DCIS BMs. When compared to invasive tumor BM-like material, EPC capsules had higher collagen density, longer and straighter fibers, but no difference in collagen type content. EPC capsules also showed less fiber alignment compared to invasive tumor BM-like material.
In addition, the study compared EPC capsules to encapsulated papillary thyroid carcinoma (EPTC) capsules and found no significant differences in capsule thickness or collagen density between the two. Both EPC and EPTC capsules were mainly composed of collagen type I and collagen type III. While EPC capsules had straighter fibers, the difference was not significant. Finally, within the EPC group, the outer part of the capsule had higher collagen density compared to the inner part. Both inner and outer parts of the EPC capsule displayed wider, longer, and straighter collagen fibers compared to other groups, and the outer part had a similar fiber width to the invasive group.
These findings suggest that EPC capsules exhibit distinct collagen characteristics, such as thickness, density, fiber composition, and alignment, which differentiate them from normal breast tissue and DCIS. However, they share similarities with EPTC capsules and exhibit variations in collagen characteristics between the inner and outer parts of the capsule.
Papillary lesions of the breast, especially encapsulated papillary carcinoma (EPC), have posed challenges in their categorization as either in situ or invasive disease. This categorization is critical for clinical management decisions. A study examined the characteristics of the basement membrane (BM) and capsule in EPC and compared them with normal breast tissue, ductal carcinoma in situ (DCIS), and invasive breast tumors.
The study found that normal breast tissue exhibited a BM with collagen type III fibers that were thinner, shorter, and more curved. DCIS had BMs similar to normal tissue but denser collagen fibers with less alignment. In contrast, the BM-like material surrounding invasive tumors had a high density of collagen fibers, primarily collagen type I, which were thicker, shorter, straighter, and less aligned.
EPCs presented with a thickened capsule with dense collagen fibers enriched in collagen type I, resembling the BM-like material around invasive tumors. There was marked heterogeneity within EPC capsules, with the outer part exhibiting features more similar to invasive tumors.
The study’s findings support the hypothesis that EPCs are invasive carcinomas with indolent behavior and an expansile growth pattern, rather than in situ lesions with a thickened BM. These characteristics align with other papillary tumors in various organs, which exhibit BM-like material and indolent behavior. The presence of collagen IV and laminin in EPCs was considered insufficient evidence for an in situ diagnosis, as these components can also be found in some invasive cancers.
In summary, EPCs display unique characteristics in their capsule and BM-like material, challenging their categorization as in situ or invasive. The study suggests that EPCs share more similarities with invasive carcinomas and highlights the importance of further investigation into the mechanisms underlying these phenomena in papillary tumors across different organs.
Oncology Related Tools
- Prognostic Scoring for Myelofibrosis
- Opioid Conversion Calculator
- Updated Advanced Opioid Conversion Calculator
- Nonsteroidal anti-inflammatory drugs (NSAID) Selection Tool
- Absolute Neutrophil Count Calculator
- Body Surface Area (BSA) Multi-Calc
- Carboplatin AUC Calculator
- Carboplatin AUC – Updated Version
- Urinary Indices, Renal Failure Index (RFI) and Fractional Excretion of Sodium (FE-NA)
- Creatinine Clearance (CRCL) – Standard Calculator
- Creatinine Clearance Multi-Calc – All of the latest research
- Patient Controlled Analgesia (PCA) Settings
- Intravenous Antineoplastic Agents – Administration Guidelines
- Therapeutic Drug Levels
- Beers Criteria for potentially inappropriate medications
- Allergic response? 12-step desensitization protocol
- Protein requirements calculator
- Basal Metabolic Rate (BMR) Multi-calc (Estimate caloric requirements)
- Irritable Bowel Syndrome Treatment Options
- Common Anti-emetics
- Fall Assessment – Berg Balance Scale
- Ibrutinib Treatment In Waldenström Macroglobulinemia
- Eyelid Carcinoma (SGC): A Tool To Predict Recurrence
- Stomach Cancer: A Meta-Analysis Of Robotic Surgery Complications
- Cognitive Behavioral Therapy In Patients With Insomnia And Chronic Fatigue
- Chemotherapy-Induced Thrombocytopenia In Nasopharyngeal Carcinoma
- Endocrine Therapy Outcomes In Senior Breast Cancer Patients
- Hepatocellular Treatment Outcomes: The Influence Of Butyrate Producers
- Non-Invasive Breast Carcinoma Treatment Outcomes
- Control Of Allergic Rhinitis And Asthma Test: A COSMIN Analysis
- Pilonidal Sinus Disease And Carcinoma Prevalence
- Sintilimab And Docetaxel Treatment Comparison In Advanced Lung Cancer
- Tislelizumab Treatment And Quality Of Life In Lung Cancer Patients
- Ciclopirox Hydrolacquer Therapy For Adult Onychomycosis
- Allergic Rhinitis And Genetic Risk Factors
- Serum Potassium Levels And Mortality Risk In CKD
- Postoperative Delirium In The NICU: Hormonal Risk Factors
- Onychomycosis And Diabetic Foot Syndrome
- Childhood BMI And Allergies: A Comprehensive Review
- Pediatric Onychomycosis Prevalence: A Systemic Review
- Hormone Disturbances In Migraine Disorder: A Meta-Analysis
- IGF-1 Levels In Pediatric Low-Level Gliomas
- Visual Field Defects In Patients With Pituitary Tumors
- Chronic Spontaneous Urticaria: Studying Age-Specific Therapies
- Levothyroxine Treatment In Patients With Thyroid Cancer
- Ocular Surgery In Infants And Post-Op Eye Drop Risks
- Cancer Care: Gender Bias In Decision-Making
- Respiratory Syncytial Virus Infection: A Tool For Assessing Clinical Severity
- Gynecologic Cancer Survivors: A Study Of Lifestyle Factors
- Non-Hodgkin Lymphoma Survivors: Secondary Malignancy Risk
- Antithyroid Drug Therapy And Cardiovascular Morbidity
- Eosinophilic Dermatosis In Hematological Malignancy (EDHM): Case Study Reports
- Uterine Leiomyosarcoma: A-Meta Analysis Of Systemic Therapy Effectiveness
- Off-Label Medication Use In Oncology
- Monocytosis And Patient Risk Of Malignancy And Mortality
- Bedside Pediatric Early Warning System: A Validation Study
- Chronic Hyponatremia In Heart Failure
- Massage Therapy For Oncology Patient Pain
- Eyelid Rhabdomyosarcoma Survival In Children’s Oncology
- Injured Athletes: A Meta-Analysis Comparing Topical And Oral Analgesic Efficacy
- Acute Myeloid Leukemia And Diverse Patient Survival Outcomes
- Sarcopenia And Chronic Kidney Disease
- Childhood Obesity: Targeted Dietary Interventions
- Supragastric Belching And Acid Reflux Severity
- Diabetic Peripheral Neuropathy Diagnosis Using Nerve Ultrasonography
- IBD: A Link To Cancer And Infection
- Renal Transplant Risks With Prostate Cancer
- COPD Risk With Diabetes And Pre-Diabetes
- Urothelial Carcinoma – Uretal And Renal Pelvic Tumors
- Merkel Cell Carcinoma: A Case Of Metastasis To The Tonsils
- Infant Formula Protein Content And Childhood Obesity
- Maternal Migraines And Associated Pediatric Cancers
- Pediatric Neuroblastoma Diagnosis Using Urinary Catecholamine Metabolites
- Finerenone Therapy In CKD And Type 2 Diabetes
- Binge Eating Habits And Diabetic Implications
- Pain Intensity In Idiopathic Inflammatory Myopathies And Rheumatic Diseases
- Melanoma Diagnosis Without Biopsy
- Pediatric Opioids And Pain Control In Fractures
- Daikenchuto Treatment For Chronic Constipation
- Prenatal Gingivitis Prevalence In A Clinical Trial Exploring Oral Hygiene Education
- Autistic Adults: A Study On Cognitive Therapy Experiences
- The Impact Of Long-Term Opioid Treatment On Endocrine Parameters
- Skeletal Muscle Index And Ovarian Cancer Prognosis: A Meta-Analysis
- Diabetes Mellitus During The Pandemic
- Carfilzomib Therapy In Pediatric Acute Lymphoblastic Leukemia
- Golimumab Compliance In Long-Term Arthritis Treatment
- Medullary Thyroid Cancer And Vocal Cord Paralysis
- Primary Adenocarcinoma Of The Orbit: A Case Study
- Survival Trends: Pancreatic Cancer in the USA
- Nusinersen Therapy For Pediatric Spinal Muscular Atrophy
- Pediatric Liver Transplantation: A New Biological Abdominal Wall
- Influenza Surveillance: A Review Of Data Sources
- Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study
- Dry Eye Disease And Dehydration
- Macular Edema Therapy Using Dexamethasone Nanoparticle Suspension
- Colorectal Cancer Screening For Older Adults
- Satiation And Satiety: An Overview And Clinical Calculator
- Cholesterol Screening To Aid In Glaucoma Detection
- Hearing Screening After Chemotherapy: A Study On Childhood Cancer Survivors
- Olfactory Dysfunction and Screening For Depression: A QOL Study
- Cancer Diagnosis And Mental Health
- Mental Health Screening In Psoriatic Arthritis Patients
- Prostate Cancer: A New Biopsy Risk Calculator Using MRI
- Mental Health Study in Cancer Survivors
- Mental Health Screening In The Community
- Bone Mineral Density Screening Combined With Mammography
- Bone Mineral Density In Type 1 Diabetes Mellitus
- Cochlear Implants and Vestibular Screening
- Aprocitentan In Resistant Hypertension
- Predicting Cardiovascular Disease With Body Mass Index
- Obesity Screening To Predict Hot Flashes
- Hypertension Screening For Cardiovascular Health
- Dental Screening For Cardiovascular Disease Risk
- Blood Pressure and CVD Risk Reduction
- Lifestyle Changes For Hypoglycemia Prevention
- Ovarian Adenocarcinoma With Glaucoma: A Case Report
- Community Hypertension and Atherosclerosis Risk
- Thyroid Malignancy and Serum Calcitonin
- Rare Schwannoma In Lateral Nasal Wall
- Pyrotinib Therapy In HER2+ Breast Cancer
- Osteopenia Predicts Outcomes in Pancreatic Cancer
- Outcomes of Physical Exercise Regimens in Advanced Cancer
- Penile Squamous Cell Carcinoma And HPV
- Radiation Therapy And VTE Risk
- Pseudouveitis With Pancreatic Carcinoma: A Case Study
- Cancer Prevention In Rural Communities
- Skeletal Muscle Mass and Cancer Patient Quality of Life: A Meta-Analysis
- Incidence of Secondary Cancers After CIRT VS RT
- Filanesib Combination Therapy in Multiple Myeloma
- Pediatric Leukemia Patients Utilizing Levofloxacin
- Breast Cancer And An Analysis Of Cardiovascular Events
- Monotherapy Or Chemotherapy Adjunct: Pembrolizumab in Advanced NSCLC
- Advanced Gastric Cancer: Prognosis with Nivolumab Monotherapy
- Sinonasal B‐Cell Lymphomas A Cohort Study On Progression And Recurrence
- Platinum Resistant Recurrent Ovarian Cancer Treatment+/-Bevacizumab
- Metastatic Melanoma and Follow-Up MRI Scans
- Isatuximab Treatment in Refractory T-Acute Lymphoblastic Leukemia
- Ocular Melanoma and Treatment with Metformin
- Gastric Neuroendocrine Neoplasms
- Lung Cancer with Brain Metastasis After Late-Onset Bipolar Disorder: A Case Report
- Anlotinib with Camrelizumab in Lung Cancer Treatment
- Sebaceous Carcinoma Treatment Outcomes: A Multicenter Study
- Diffuse-Type Tenosynovial Giant Cell Tumors: Treatment and Progression
- Lung Spindle Cell Carcinoma Responsive to Pembrolizumab: A Rare Case Report
- DNA Methylation Profiling in Sarcoma Classification
- Breast Tomosynthesis Simulator For Virtual Clinical Trials
- Renal Cell Carcinoma-Prognosis Via Albumin Levels
- Diagnostic Error Causing Cases of Cytopenia
- Hodgkin’s Lymphoma: A Case Study With Nystagmus and Diplopia
- Brugada Syndrome Treated with Lenalidomide: A Case Study
- Koolen-de Vries Case Study
- Suicidal Ideation and Somatic Treatments
- Study on Pavlovian Fear Conditioning and Fear Reversal in OCD
- Anxiety Scales in Lewy Body Disease
- Inoperable Locally Advanced Non-Small Cell Lung Cancer: Survival Rates of Endostar, CCRT
- Physician Practice Management and Private Equity
- Physician Spending And Its Association With Patient Outcomes
- Physician Burnout: Causes and Prevention
- LEAP-MS: Adaptations for Advanced Stages
- MS: Exercise Impacts on MRI
- The Role of Preretirement Job Complexity in Cognitive Performance
- Extrapontine Myelinolysis and PTA in Pregnancy
- Verbal Communication and Masks
- Sugammadex Versus Neostigmine in Thyroidectomy
- SGLT Inhibitors on Weight and Lipid Metabolism in Diabetes
- Saxagliptin: Obese Patients with Impaired Glucose Tolerance
- Levothyroxine Therapy and Depression
- Grave’s Disease and Risk of Systemic Lupus Erythematosus
- Benign Thyroid Removal and Patient Satisfaction
- MF- Biology, Management, and a Case Study of Ocular Manifestation
- Quality Of Life In Adolescent Cancer Survivors
- Cancer Opioid Risk Score
- Oncology-Specific Opioid Risk Calculator In Cancer Survivors
- 3D MRI for Non-invasive Ocular Proton Therapy of Uveal Melanomas
- Sexual Dysfunction in Prostate Cancer Patients
- 3-Day Surprise Question To Predict Survival Rates in Advanced Cancer Patients